SCHEMBL18656997

SCHEMBL18656997

C/C=C/c1ccccc1Oc1ccc(C(C)=O)cc1

nearest known ligand 0.54

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
GAA P10253 2/20 0.54
HPGD P15428 2/20 0.53
MAPT P10636 1/20 0.53
RAB9A P51151 1/20 0.53
HTT P42858 2/20 0.53
MAOB P27338 2/20 0.47
LMNA P02545 6/20 0.46
ALDH1A1 P00352 2/20 0.46
CYP1A2 P05177 1/20 0.46
CYP2C9 P11712 1/20 0.46
CYP2C19 P33261 1/20 0.46
SMN1; SMN2 Q16637 1/20 0.46
KMT2A Q03164 4/20 0.46
PARP10 Q53GL7 1/20 0.44
TLR4 O00206 1/20 0.43
TLR2 O60603 1/20 0.43
KDM4E B2RXH2 1/20 0.43
MEN1 O00255 1/20 0.41
L3MBTL1 Q9Y468 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18627999 1.00 GAA (0.54) GAAHPGDMAPTRAB9AHTT
SCHEMBL18628000 1.00 GAA (0.54) GAAHPGDMAPTRAB9AHTT
SCHEMBL158895 0.89 GAA (0.55) GAAHPGDHTTMAOBLMNA
SCHEMBL29399051 0.89 GAA (0.55) GAAHPGDHTTMAOBLMNA
SCHEMBL25498288 0.89 GAA (0.55) GAAHPGDHTTMAOBLMNA
SCHEMBL12227188 0.89 GAA (0.55) GAAHPGDHTTMAOBLMNA
SCHEMBL158896 0.89 GAA (0.55) GAAHPGDHTTMAOBLMNA
SCHEMBL29533606 0.89 GAA (0.55) GAAHPGDHTTMAOBLMNA
SCHEMBL9504456 0.87 GAA (0.56) GAAMAPTRAB9AHTTMAOB
SCHEMBL9504448 0.87 GAA (0.56) GAAMAPTRAB9AHTTMAOB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3541773-B1 ASYMMETRICALLY SUBSTITUTED BIS-ALKENYL DIPHENYL ETHERS, THEIR PREPARATION AND USE EVONIK OPERATIONS GMBH (DE) 2020-05-13 EP disclosed
US-20190367652-A1 ASYMMETRICALLY SUBSTITUTED BIS-ALKENYL DIPHENYL ETHERS, THEIR PREPARATION AND USE EVONIK TECHNOCHEMIE GMBH (DE) 2019-12-05 US disclosed
US-10233139-B2 Alkenylphenoxy-substituted 1,1-diphenylethylenes, processes for their preparation, and their use EVONIK TECHNOCHEMIE GMBH (DE) 2019-03-19 US disclosed
US-20180201561-A1 ALKENYLPHENOXY-SUBSTITUTED 1,1-DIPHENYLETHYLENES, PROCESSES FOR THEIR PREPARATION, AND THEIR USE EVONIK TECHNOCHEMIE GMBH (DE) 2018-07-19 US disclosed
WO-2018091253-A1 ASYMMETRICALLY SUBSTITUTED BIS-ALKENYL DIPHENYL ETHERS, THEIR PREPARATION AND USE EVONIK TECHNOCHEMIE GMBH (DE) 2018-05-24 WO disclosed
WO-2017045932-A1 ALKENYLPHENOXY-SUBSTITUTED 1,1-DIPHENYLETHYLENES, PROCESSES FOR THEIR PREPARATION, AND THEIR USE EVONIK TECHNOCHEMIE GMBH (DE) 2017-03-23 WO disclosed
EP-3144290-A1 ALKENYLPHENOXY-SUBSTITUTED 1,1-DIPHENYLETHYLENES, PROCESSES FOR THEIR PREPARATION, AND THEIR USE Evonik Technochemie GmbH (DE) 2017-03-22 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180201561-A1 ALKENYLPHENOXY-SUBSTITUTED 1,1-DIPHENYLETHYLENES, PROCESSES FOR THEIR PREPARATION, AND THEIR USE MACF1, COL1A1, PLOD1 GAA 4566/4885HPGD 448/4885MAPT 630/4885
US-20190367652-A1 ASYMMETRICALLY SUBSTITUTED BIS-ALKENYL DIPHENYL ETHERS, THEIR PREPARATION AND USE ITGB3, C9, CBR3 GAA 4773/4885HPGD 1007/4885MAPT 647/4885
US-10233139-B2 Alkenylphenoxy-substituted 1,1-diphenylethylenes, processes for their preparation, and their use MACF1, COL1A1, PLOD1 GAA 4535/4885HPGD 632/4885MAPT 678/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.